In 2026, the biggest innovation in the market is the shift toward Extended-Release (ER) Alprazolam Formulations. In 2026, pharmaceutical companies are heavily marketing 2mg ER tablets designed to provide a steady, 24-hour therapeutic effect, reducing the "highs and lows" associated with immediate-release versions. These 2026 formulations are being hailed as a safer alternative for chronic panic...